MAP Pharmaceuticals Report issue

For profit Phase 3
Founded: Mountain View CA United States (2003)
Status: Acquired by Allergan (2013) → now GlaxoSmithKline (2000)

Organization Overview

First Clinical Trial
2007
NCT00569192
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

budesonide (rhinocort) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1